Should growth hormone be covered for treating short stature?
Guidelines ‘unmanageable’ in UK general practice
Use GP IIb/IIIa receptor antagonists in acute coronary syndromes
Access to healthcare has limited effect on outcomes?
What makes a good guideline?
DM programmes : lack of evaluation akin to medical negligence
Nit-picking over Lyme disease study
Shortcomings in hypertension treatment
Epoetin-alfa not worthwhile in chemotherapy-induced anaemia
Managed-care HIV costs levelling out
Preventing vertical HIV transmission in rural South Africa
Warfarin cost effective for stroke prevention in the elderly
News in brief …
Which treatment for unresectable colorectal liver metastases?
Liposomal doxorubicin good value in Kaposi's sarcoma
How ‘staggering’ is the economic burden of schizophrenia?
Treating DVT and PE at home a feasible option
News in brief …
Quality of Life Aspects
Chemotherapy-related fatigue has sweeping impact on well-being
Coping strategies predict variance in QOL in cystic fibrosis
News in brief …
Regulatory issues for ‘Viagra’ in European countries
Australia's healthcare costs higher in women than men
Diabetes numbers to double by 2025